Shanghai Allist Pharmaceuticals Co., Ltd. Stock
Equities
688578
CNE100005XJ7
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
64.62 CNY | -2.18% | +4.09% | +55.11% |
Sales 2023 | 2.01B 279M | Sales 2024 * | 2.98B 412M | Capitalization | 29.08B 4.03B |
---|---|---|---|---|---|
Net income 2023 | 645M 89.29M | Net income 2024 * | 1.05B 146M | EV / Sales 2023 | 9.32 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 9.76 x |
P/E ratio 2023 |
29.1
x | P/E ratio 2024 * |
27.6
x | Employees | 870 |
Yield 2023 |
0.96% | Yield 2024 * |
0.77% | Free-Float | 34.03% |
1 day | -2.18% | ||
1 week | +4.09% | ||
Current month | +4.09% | ||
1 month | +40.26% | ||
3 months | +60.55% | ||
6 months | +72.37% | ||
Current year | +55.11% |
Managers | Title | Age | Since |
---|---|---|---|
Jin Hao Du
CEO | Chief Executive Officer | 70 | 04-03-21 |
Feng Xu
BRD | Director/Board Member | 59 | 16-12-31 |
Jie Hu
BRD | Director/Board Member | 49 | 19-06-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Yan
BRD | Director/Board Member | 42 | 19-11-27 |
Jin Hao Du
CEO | Chief Executive Officer | 70 | 04-03-21 |
Rong Gang Xie
BRD | Director/Board Member | 39 | 19-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 64.62 | -2.18% | 9,710,229 |
24-05-07 | 66.06 | -2.25% | 13,654,040 |
24-05-06 | 67.58 | +8.86% | 16,658,250 |
24-04-30 | 62.08 | +7.26% | 18,346,980 |
End-of-day quote Shanghai S.E., May 07, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+55.11% | 4.12B | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- 688578 Stock